Michal Agami

Title: Michal Agami: Innovator in Pharmaceutical Compositions

Introduction

Michal Agami is a notable inventor based in Netanya, Israel. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on meloxicam compositions. His expertise and dedication to research have led to advancements that benefit the medical community.

Latest Patents

Michal Agami holds a patent for "Pharmaceutical compositions comprising meloxicam and methods of their preparation." This invention encompasses a method of evaluating pharmaceutical compositions of meloxicam, allowing for a correlation between in vitro properties and in vivo properties. The pharmaceutical compositions developed using this method are expected to enhance therapeutic outcomes.

Career Highlights

Agami is currently associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. His role at Teva has allowed him to work on groundbreaking research and development projects that aim to improve patient care and treatment options.

Collaborations

Throughout his career, Michal has collaborated with talented professionals, including Julia Hrakovsky and Ruth Tenengauzer. These collaborations have fostered an environment of innovation and creativity, leading to the development of effective pharmaceutical solutions.

Conclusion

In summary, Michal Agami is a distinguished inventor whose work in pharmaceutical compositions has the potential to significantly impact the healthcare industry. His contributions, particularly in the area of meloxicam, demonstrate his commitment to advancing medical science.